Indicated for: chronic hepatitis C
Substance: boceprevir (antiviral)
ATC: J05AE12 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)
Boceprevirum is an antiviral medication used for the treatment of chronic hepatitis C, particularly in patients infected with genotype 1 of the hepatitis C virus. It is an NS3/4A protease inhibitor that blocks the replication of the virus in liver cells.
The medication is taken orally, usually in combination with other antiviral drugs such as ribavirin and pegylated interferon. The treatment is long-term and requires regular monitoring to assess the patient's response.
Common side effects include fatigue, nausea, anemia, headache, and taste changes. In rare cases, severe allergic reactions or depression may occur, which is why patients must be closely monitored.
Boceprevirum is not recommended for pregnant or breastfeeding women, as it may affect fetal development. Additionally, patients should inform their doctor about all medications they are taking to avoid drug interactions.